Relay Therapeutics shares rise 2.19% after-hours following Brian Adams' appointment as Kymera Therapeutics' Chief Legal Officer.

miércoles, 3 de septiembre de 2025, 5:58 pm ET1 min de lectura
RLAY--
Relay Therapeutics, Inc. rose 2.19% in after-hours trading, following the news that Brian Adams, the former Chief Legal Officer of Relay Therapeutics, has been appointed as the new Chief Legal Officer and Corporate Secretary of Kymera Therapeutics, Inc. This move indicates a positive transition for Adams, who was responsible for leading all aspects of Relay's legal and compliance operations.

Relay Therapeutics shares rise 2.19% after-hours following Brian Adams' appointment as Kymera Therapeutics' Chief Legal Officer.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios